Case Study: AggreGuard with VERO Cells

AggreGuard™: VERO cells case study

The reported findings highlight the potential to improve VERO upstream bioprocessing efficiency for existing batch/fed-batch modes using AggreGuard™.

Experimental design considerations:

  • Cell type and microcarrier (MC) selection screens (if data is unknown).
  • AggreGuard™ time-dose response screening in multi-well plates to evaluate cell type (i.e., extracellular matrix composition, attachment behaviour, doubling time, etc.), microcarrier selection and media formulation.

Read our full case study below.

Related Blogs

(Newcastle Upon Tyne, 11th June 2025) The Kuraray Life Innovation Business Promotion Department, a division of Kuraray Co., Ltd. (TYO: 3406), a …

Except for hematopoietic-derived cells, most cells isolated from animals are naturally adherent. In vivo, adherent cells interact with their surrounding environment and …

CellRev launches its proprietary media additive AggreGuard™ which prevents aggregation of adherent cells and increases cell yield in existing VERO processes CellRev, …

Share